Savara Inc. (SVRA) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Savara Inc. (SVRA) Bundle
Designed for accuracy, our (SVRA) DCF Calculator enables you to assess Savara Inc.'s valuation using real-world financial data, providing complete flexibility to modify all key parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -77.1 | -47.4 | -40.4 | -37.9 | -59.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -18459.14 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | 1.0 | .7 | .4 | .2 | .2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 269.65 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -78.1 | -48.1 | -40.7 | -38.1 | -59.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -18728.79 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | 121.8 | 82.2 | 161.2 | 125.9 | 162.3 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.6 | 1.7 | 1.1 | 1.0 | 1.0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 659.53 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | -1.6 | -1.7 | -1.1 | 2.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | -659.53 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | 3.4 | 2.6 | 1.4 | 1.3 | 3.5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 1009.73 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.1 | -3.3 | -.1 | .0 | -.3 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | -1281.71 | 100 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -104.9 | -49.6 | -42.9 | -38.9 | -59.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -100.7 | -53.0 | -43.7 | -41.8 | -55.3 | -2.5 | .0 | .0 | .0 | .0 |
| WACC, % | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 | 9.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -2 | |||||||||
| Diluted Shares Outstanding, MM | 165 | |||||||||
| Equity Value Per Share | -0.01 |
What You Will Get
- Real SVRA Financials: Access historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Explore various scenarios to assess Savara Inc.'s future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive SVRA Data: Pre-filled with Savara Inc.’s historical performance metrics and future outlooks.
- Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax implications, and capital investments.
- Adaptive Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecast scenarios to evaluate different valuation results.
- User-Friendly Interface: Intuitive, organized, and tailored for both industry professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Savara Inc. (SVRA) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Savara Inc.'s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose Savara Inc. (SVRA)?
- Save Time: Quickly access comprehensive data without the hassle of building from the ground up.
- Enhance Accuracy: Dependable financial metrics and methodologies minimize valuation errors.
- Fully Customizable: Adjust the model to align with your specific assumptions and forecasts.
- Simple to Analyze: Intuitive graphs and outputs facilitate straightforward interpretation of results.
- Endorsed by Professionals: Crafted for experts who prioritize both precision and functionality.
Who Should Use Savara Inc. (SVRA)?
- Investors: Gain insights into the biopharmaceutical sector with a reliable investment analysis tool.
- Financial Analysts: Streamline your workflow with customizable financial models tailored for Savara Inc. (SVRA).
- Consultants: Efficiently modify the framework for client presentations or strategic reports on Savara Inc. (SVRA).
- Biotech Enthusiasts: Enhance your knowledge of the industry through detailed case studies and market analysis.
- Educators and Students: Utilize it as a hands-on resource in courses focused on biotechnology and finance.
What the Template Contains
- Pre-Filled Data: Includes Savara Inc.’s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Savara Inc.’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.